RecruitingNCT04669886
Serum Endotoxin Assay to Predict the Development of Postoperative Infectious Complications and Systemic Inflammatory Response Following Percutaneous Nephrolithotomy.
Sponsor
University of Miami
Enrollment
150 participants
Start Date
Nov 1, 2023
Study Type
OBSERVATIONAL
Conditions
Summary
The aim of the study is to establish an infectious risk stratification system based on pre-and post-operative blood endotoxin profile.
Eligibility
Min Age: 18 Years
Inclusion Criteria3
- Adults that is able to consent (≥ 18 years of age)
- Scheduled to undergo PCNL at Uhealth tower and Jackson Memorial Hospitals
- not currently immunosuppressed \[White blood count (WBC) \>= 2, not on immunosuppressive medications\]
Exclusion Criteria2
- unable to consent and \< 18 years of age
- currently immunosuppressed (WBC \< 2, not on immunosuppressive medications)
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04669886
Related Trials
ClearPetra™ Vacuum-assisted Ureteral Access Sheath vs Traditional Approach
NCT065476321 location
Comparison of Extracorporeal Shock Wave Lithotripsy Versus Retrograde Intrarenal Surgery in the Management of Renal Calculi
NCT072619951 location
Intravesical Bupivacaine on Post-Operative Ureteroscopy Pain
NCT066358891 location
Comparison Between Ureterorenoscopy With Lithotripsy Alone Versus Combination With Hydrogel for Kidney Stone Removal
NCT064697361 location
Alpha-Blockers Prior to Ureteral Access Sheath Placement in Flexible Ureteroscopy: A Randomized Prospective Study
NCT071242991 location